Antiviral agent 61
Antiviral agent 61 (compound Z40) is a potent antiviral agent. Antiviral agent 61 shows anti tomato spotted wilt virus (TSWV) activity with an EC50 value of 252 μg/mL. Antiviral agent 61 increases the RNA expression of Ndufb9,COX6B,7.1.2.2,E,COX5B,Ndufs4,and SDHB,decreases the RNA expression of Ndufb7,Ndufa5,and G.
For research use only. We do not sell to patients.
- Formula: C22H23N5O4S
- Molecular Weight:453.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
Molecular Weight 453.51
-
Formula C22H23N5O4S
-
SMILES
[O-]C1=C(C(N2CCN(S(=O)(C3=CC=C(C)C=C3)=O)CC2)=O)[N+]4=CC=CC=C4N1CCC#N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Protocol for Northern Blot
Northern blot detects a defined RNA species by separating denatured RNA by size, transferring RNA to a membrane, hybridizing with a complementary labeled DNA or RNA probe, and detecting probe-bound RNA by autoradiography, phosphorimaging, or validated nonradioactive detection. The readout is both RNA size and abundance: band migration estimates transcript length or RNA-processing state, while band intensity reflects relative target RNA amount after normalization to total RNA, rRNA, or another validated loading control. In cancer cells, primary neurons, mouse tumor samples, intestinal organoids, inflammatory macrophages, or drug-screening studies, Northern blot is most appropriate when transcript size, isoform pattern, RNA processing, or small-RNA detection is important; qPCR or RNA-seq can complement it when higher sensitivity or global profiling is needed.
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)